Your genes may decide your new Liver's fate after MASH transplant
NCT ID NCT07685353
First seen Jul 06, 2026 · Last updated Jul 22, 2026 · Updated 3 times
Summary
This study looks at whether certain gene variations in the donor and the recipient influence how much fat builds up in the new liver after a living-donor transplant for MASH-related cirrhosis. Researchers will compare genetically related and unrelated donor-recipient pairs to separate genetic from environmental effects. The goal is to understand why fatty liver disease sometimes returns after transplant, which could eventually help improve long-term outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If certain gene variants are linked to fat recurrence, doctors could better match donors and recipients to protect the new liver.
- What could go wrong
- This is an observational study with only 50 participants, so findings may not apply to everyone. Genetic factors are just one piece of a complex puzzle.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LIVER DISEASE AND CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Liver and Biliary Sciences
RECRUITINGNew Delhi, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.